Drug delivery device

US9586009B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9586009-B2
Application numberUS-201214131646-A
CountryUS
Kind codeB2
Filing dateJul 12, 2012
Priority dateJul 15, 2011
Publication dateMar 7, 2017
Grant dateMar 7, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A drug delivery device comprising; a housing; a cylindrical member configured to be rotatably supported inside the housing, wherein the outer surface of the cylindrical member is provided with at least first and second tracks together forming an encoder, each track comprising conductive segments and non-conductive segments; and at least first and second groups of contacts configured to engage the first and second tracks respectively at predetermined intervals along the length of the track.

First claim

Opening claim text (preview).

The invention claimed is: 1. A drug delivery device comprising: a housing; a cylindrical member configured to be rotatably supported inside the housing, wherein the outer surface of the cylindrical member is provided with at least first and second tracks together forming an encoder, each track comprising conductive segments and non-conductive segments, and wherein the at least first and second tracks are separated by a non-conductive strip; at least first and second groups of contacts configured to engage the first and second tracks respectively at predetermined intervals along the length of the track; a switch configured: in a first position, to connect electrically the first and second tracks, and in a second position, to isolate electrically the first and second tracks; and a processor configured: to cause a first electrical signal to be applied to a first contact of the second group of contacts and simultaneously to monitor electrical signals at the first group of contacts, and if electrical signals are not detected at any of the first group of contacts, to cause a second electrical signal to be applied to a second contact of the second group of contacts and simultaneously to monitor electrical signals at the first group of contacts. 2. The drug delivery device of claim 1 , wherein the tracks are helical tracks and wherein the housing and the cylindrical member are configured such that the cylindrical member moves in a first axial direction relative to the housing when rotated in a first rotational direction relative to the housing. 3. The drug delivery device of claim 1 , wherein the cylindrical member is configured to be rotatable from an initial position into a number of discrete rotational positions, and wherein the contacts of the first group of contacts are arranged such that the sequence of conductive and non-conductive segments engaged by the contacts of the first group of contacts in successive discrete rotational positions forms a Gray code. 4. The drug delivery device of claim 1 , wherein the encoder has a higher bit depth than each individual track. 5. The drug delivery device of claim 1 , wherein coding depths of the at least two tracks are combined such that a combined coding depth of the encoder comprising the at least first and second track equals the sum of the individual coding depth of each track. 6. The drug delivery device of claim 1 , wherein each of the at least two tracks comprises a single track bit code. 7. The drug delivery device of claim 1 , wherein the first group of contacts comprises more contacts than the second group of contacts. 8. The drug delivery device of claim 7 , wherein the first group of contacts comprises five contacts and the second group of contacts comprises two contacts. 9. The drug delivery device of claim 1 , wherein the contacts of the first group of contacts are spaced such as to engage every sixth segment of the first track and wherein the contacts of the second group of contacts are spaced such as to engage every twenty-seventh segment of the second track. 10. The drug delivery device of claim 1 , further comprising a user actuatable plunger configured to cause expulsion of a drug from the drug delivery device, and wherein depression of the plunger causes the switch to switch from the first position to the second position. 11. The drug delivery device of claim 1 , wherein the conductive segments within each of the first and second tracks are electrically connected to all of the other conductive segments in that track. 12. The drug delivery device of claim 11 , wherein the conductive segments within each of the first and second tracks are electrically connected together by first and second common ground tracks immediately adjacent to respective ones of the first and second tracks. 13. The drug delivery device of claim 1 , wherein the conductive and non-conductive segments of the first and second tracks are arranged such that, when the cylindrical member is in an initial position, each contact is configured to engage a conductive segment. 14. The drug delivery device of claim 1 , wherein the device further comprises: a display, and wherein the processor is further configured to control the operation of the display. 15. The drug delivery device of claim 1 , wherein the processor is further configured to: responsive to detecting no signals at any of the first group of contacts when the second electrical signal is applied to the second contact of the second group of contacts, cause a third electrical signal to be applied to a first contact of the first group of contacts and simultaneously to monitor electrical signals at the other contacts of the first group of contacts.

Assignees

Inventors

Classifications

  • Dosing (burettes, pipettes B01L3/02) · CPC title

  • Optical measuring means · CPC title

  • Specific display means related to dosing · CPC title

  • Means preventing setting of a dose beyond the amount remaining in the cartridge · CPC title

  • with memories providing a history of measured variating parameters of apparatus or patient · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9586009B2 cover?
A drug delivery device comprising; a housing; a cylindrical member configured to be rotatably supported inside the housing, wherein the outer surface of the cylindrical member is provided with at least first and second tracks together forming an encoder, each track comprising conductive segments and non-conductive segments; and at least first and second groups of contacts configured to engage t…
Who is the assignee on this patent?
Butler Joseph, Moore David, Draper Paul Richard, and 3 more
What technology area does this patent fall under?
Primary CPC classification A61M5/31551. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Mar 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).